The best indicator for Colgate-Palmolive (CL)
We backtested 20 indicators across daily, weekly and hourly charts on real Colgate-Palmolive (CL) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Stochastic
On the daily chart, this is the strongest risk-adjusted edge we found for Colgate-Palmolive (CL) over ~53.1 years — trailing buy-and-hold by 3.3% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Stochastic ✓ | Daily | 7.3% | 0.53 | -42.2% | 74.1% | 270 | -3.3% |
| 2 | Stochastic ✓ | Weekly | 6.1% | 0.53 | -23.5% | 86.4% | 44 | -4.4% |
| 3 | Bollinger Mean-Reversion ✓ | Daily | 5.9% | 0.48 | -44.7% | 69.7% | 221 | -4.7% |
| 4 | Money Flow Index ✓ | Daily | 6.4% | 0.48 | -51.5% | 90.4% | 52 | -4.1% |
| 5 | WaveTrend (8/6/4) ✓ | Weekly | 6.5% | 0.48 | -30.0% | 88.4% | 43 | -4.1% |
| 6 | CCI ✓ | Weekly | 5.7% | 0.46 | -25.7% | 83.0% | 53 | -4.8% |
| 7 | Williams %R ✓ | Daily | 6.3% | 0.45 | -40.0% | 70.9% | 354 | -4.2% |
| 8 | Williams %R ✓ | Weekly | 6.1% | 0.44 | -38.5% | 76.1% | 71 | -4.4% |
| 9 | CCI ✓ | Daily | 5.7% | 0.42 | -44.6% | 68.5% | 267 | -4.8% |
| 10 | RSI Mean-Reversion ✓ | Daily | 3.7% | 0.4 | -26.1% | 76.7% | 73 | -6.8% |
| 11 | Holy Grail Confluence ✓ | Daily | 4.9% | 0.4 | -35.0% | 76.6% | 77 | -5.7% |
| 12 | Bollinger Mean-Reversion ✓ | Weekly | 4.4% | 0.4 | -23.5% | 83.3% | 36 | -6.1% |
| 13 | WaveTrend (8/6/4) ✓ | Daily | 5.3% | 0.38 | -58.6% | 70.5% | 200 | -5.2% |
| 14 | EMA 20/50 Cross ✓ | Weekly | 5.3% | 0.36 | -58.1% | 33.3% | 27 | -5.2% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Colgate-Palmolive (CL), Stochastic on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.